How Much Did Paytient Raise? Funding & Key Investors

What Is Paytient?

Paytient is a private company based in Columbia, Missouri, that operates in the Employee Benefits, FinTech, Health Care, and Payments industries. The company has between 101-250 employees.

Paytient helps people make better healthcare decisions by improving their ability to pay for care. The company partners with employers, insurers, and health systems to offer financial solutions that allow employees to manage healthcare costs over time without interest or fees.

How Much Funding Has Paytient Raised?

1. Pre-seed
   • Amount Raised: USD 1,300,000
   • Date: June 2019
   • Lead Investors: Cultivation Capital, Lightbank
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To establish initial operations and product development.
2. Seed
   • Amount Raised: USD 3,900,000
   • Date: October 2020
   • Lead Investors: Inspired Capital Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To further develop and expand the company's offerings.
3. Series A
   • Amount Raised: USD 17,200,000
   • Date: July 2021
   • Lead Investors: Inspired Capital Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To expand the company's product offerings and market reach.
4. Series B
   • Amount Raised: USD 33,000,000
   • Date: January 2023
   • Lead Investors: Mercato Partners Traverse Fund
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To scale growth and product development. Existing investors Lightbank, Felicis Ventures, Box Group, Lachy Groom, Left Lane Capital, Commerce Bank, Crossbeam Ventures, Cultivation Capital, and Inspired Capital also participated. New investor Bertelsmann Investments joined the round.
5. Debt Financing
   • Amount Raised: USD 7,500,000
   • Date: January 2023
   • Lead Investors: Silicon Valley Bank
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: Note: Per Paytient's corrected announcement (March 15, 2023), this credit facility with Silicon Valley Bank did not close. This amount is therefore excluded from the total funding calculation.
6. Debt Financing (Growth Capital)
   • Amount Raised: USD 40,000,000
   • Date: June 2025
   • Lead Investors: Trinity Capital
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To fuel market expansion into large group employer-sponsored plans, alternative health plans, the ACA marketplace, and Medicare. Note: This is a debt/growth capital facility provided by Trinity Capital (Nasdaq: TRIN), not an equity round. Crunchbase classifies it as Series C; primary sources (Paytient and Trinity Capital press releases) describe it as growth capital/debt financing.

Total Amount Raised: At least USD 95,700,000 based on disclosed and confirmed funding (Pre-seed: $1.3M + Seed: $3.9M + Series A: $17.2M + Series B: $33M + Growth Capital Debt: $40M; the $7.5M SVB credit facility did not close per Paytient's own correction). Current Valuation: Not publicly disclosed.

Key Investors

• Mercato Partners Traverse Fund
  • Details: Mercato Partners Traverse Fund is a Utah-based investment fund. Joe Kaiser, managing director, joined Paytient's board of directors as lead investor in the Series B round.
  • Investment Focus Areas: Technology, consumer, healthcare
  • Notable Investments: Cradlepoint, Stance, Sphero
• Trinity Capital
  • Details: Trinity Capital (Nasdaq: TRIN) is a provider of growth capital and venture debt to innovative, high-growth companies. It provided Paytient with $40 million in growth capital in June 2025 to support market expansion.
  • Investment Focus Areas: Technology, healthcare, venture-backed growth companies
  • Notable Investments: Various venture-backed technology and healthcare companies
• Inspired Capital
  • Details: Inspired Capital is a venture capital firm that led Paytient's Seed and Series A rounds, and continued as an existing investor through Series B. The firm focuses on early-stage technology companies.
  • Investment Focus Areas: Technology
  • Notable Investments: Chief, Orum, Finix
• Bertelsmann Investments
  • Details: Bertelsmann Investments is the investment arm of Bertelsmann, a global media, services, and education company. Thorsten Wirkes joined Paytient's board as an observer following the Series B round.
  • Investment Focus Areas: Media, services, education, healthcare, technology
  • Notable Investments: Udacity, Relias Learning, HotChalk
• Lightbank
  • Details: Lightbank is a venture capital firm known for investing in disruptive technology companies. It has been an investor in Paytient from the pre-seed stage through Series B.
  • Investment Focus Areas: Disruptive technology
  • Notable Investments: Groupon, Tempus, Udemy

What's Next for Paytient?

Paytient stands at the cusp of significant growth opportunities, driven by the increasing need for affordable healthcare payment solutions. With a recent infusion of $40.5 million, the company is poised to expand its health payment accounts offering, partnering with more employers and insurers to provide interest-free credit for healthcare costs. This expansion could potentially reach millions of Americans struggling with out-of-pocket healthcare expenses.

Future fundraising opportunities appear promising as the demand for flexible payment plans continues to rise. The company's ability to attract high-profile investors suggests that additional funding rounds are likely, enabling further scaling and product development. However, Paytient will need to navigate challenges such as competition from other fintech solutions and ensuring compliance with regulatory requirements. Despite these hurdles, the company's proactive approach to healthcare cost management positions it well for continued success.

Use Clay to Get Funding Data

Sales professionals, leverage Clay's platform to access comprehensive fundraising data on companies like Paytient and gather other critical business insights. Sign up for free to start transforming your sales strategy today.